Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 312 (2) , 627-634
- https://doi.org/10.1124/jpet.104.074823
Abstract
Basophils are important in allergic diseases such as asthma because they produce a variety of inflammatory mediators. Activation of these cells with IgE and N-formyl-methionyl-leucyl-phenylalanine results in a variety of responses, including increased surface expression of CD203c and CD11b and release of histamine. Although considerable information is available on the effects of eicosanoids on neutrophils, eosinophils, and monocytes, less is known about their effects on basophils. In the present study, we examined the effects of various eicosanoids on the above basophil responses. Of the naturally occurring eicosanoids tested, prostaglandin D2 (PGD2; EC50, 10 nM) was by far the most potent activator of CD203c expression, with other prostanoids having little effect. This response was mediated by the DP2 receptor/chemoattractant receptor-homologous molecule expressed on Th2 cells because it was shared by the selective agonist 15R-methyl-PGD2 (EC50, 3 nM). The 5-lipoxygenase products leuko-triene B4 and 5-oxo-6,8,11,14-eicosatetraenoic acid also stimulated CD203c expression but to a lesser extent than PGD2, whereas leukotriene D4 was inactive. Neither PGD2 nor 5-oxo-6,8,11,14-eicosatetraenoic acid stimulated histamine release or CD63 expression on basophils. Both PGE2 and the DP1 receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] strongly inhibited DP2 receptor-mediated CD203c expression. The DP1 receptor antagonist BWA868C [3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)-4-imidazolidine-heptanoic acid] enhanced PGD2-induced CD203c expression, suggesting that interaction of PGD2 with DP1 receptors can limit activation of basophils by this prostaglandin. In conclusion, PGD2 is the most potent inducer of basophil CD203c expression among eicosanoids and may be a key mediator in asthma and other allergic diseases. The balance between DP1 and DP2 receptors may be important in determining the magnitude of basophil responses to this prostaglandin.Keywords
This publication has 38 references indexed in Scilit:
- The Basophil-Specific Ectoenzyme E-NPP3 (CD203c) as a Marker for Cell Activation and Allergy DiagnosisInternational Archives of Allergy and Immunology, 2004
- Marked improvement of the basophil activation test by detecting CD203c instead of CD63Clinical and Experimental Allergy, 2003
- 15 R-Methyl-Prostaglandin D2 Is a Potent and Selective CRTH2/DP2 Receptor Agonist in Human EosinophilsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Identification of a Novel Human Eicosanoid Receptor Coupled to Gi/oPublished by Elsevier ,2002
- Indomethacin Causes Prostaglandin D2-like and Eotaxin-like Selective Responses in Eosinophils and BasophilsPublished by Elsevier ,2002
- Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocationJournal of Allergy and Clinical Immunology, 2000
- Effect of misoprostol on the secretion of histamine from basophils of whole bloodAnnals of Allergy, Asthma & Immunology, 2000
- Eotaxin Is a Potent Chemotaxin for Human BasophilsBiochemical and Biophysical Research Communications, 1997
- Release of Prostaglandin D2into Human Airways during Acute Antigen ChallengeNew England Journal of Medicine, 1986
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980